PTC Therapeutics
PTCT
PTCT
179 hedge funds and large institutions have $2.84B invested in PTC Therapeutics in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 56 increasing their positions, 74 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.51% less ownership
Funds ownership: 104.39% → 103.88% (-0.51%)
2% less funds holding
Funds holding: 182 → 179 (-3)
24% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 74
Holders
179
Holding in Top 10
5
Calls
$9.26M
Puts
$8.38M
Top Buyers
| 1 | +$28M | |
| 2 | +$17.7M | |
| 3 | +$10.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$7.63M |
Top Sellers
| 1 | -$44.7M | |
| 2 | -$21.9M | |
| 3 | -$10.9M | |
| 4 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$10.2M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$7.65M |